|
1.
|
FJ FlemingL PahlmanJR MonsonNeoadjuvant
therapy in rectal cancerDis Colon
Rectum54901912201110.1007/DCR.0b013e31820eeb3721654259
|
|
2.
|
A Habr-GamaRO PerezW NadalinLong-term
results of preoperative chemoradiation for distal rectal cancer
correlation between final stage and survivalJ Gastrointest
Surg99099200510.1016/j.gassur.2004.10.01015623449
|
|
3.
|
M MaasRG Beets-TanDM LambregtsWait-and-see
policy for clinical complete responders after chemoradiation for
rectal cancerJ Clin
Oncol2946334640201110.1200/JCO.2011.37.717622067400
|
|
4.
|
AL HarrisHypoxia - a key regulatory factor
in tumour growthNat Rev Cancer23847200210.1038/nrc70411902584
|
|
5.
|
LH GrayAD CongerM EbertS HornseyOC
ScottThe concentration of oxygen dissolved in tissues at the time
of irradiation as a factor in radiotherapyBr J
Radiol26638648195310.1259/0007-1285-26-312-63813106296
|
|
6.
|
GL WangBH JiangEA RueGL
SemenzaHypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS
heterodimer regulated by cellular O2 tensionProc Natl
Acad Sci USA9255105514199510.1073/pnas.92.12.55107539918
|
|
7.
|
D VordermarkJM BrownEndogenous markers of
tumour hypoxia predictors of clinical radiation
resistance?Strahlenther
Onkol179801811200310.1007/s00066-003-1150-914652668
|
|
8.
|
UR JewellI KvietikovaA ScheidC BauerRH
WengerM GassmannInduction of HIF-1alpha in response to hypoxia is
instantaneousFASEB J1513121314200111344124
|
|
9.
|
GL SemenzaDefining the role of
hypoxia-inducible factor 1 in cancer biology and
therapeuticsOncogene29625634201010.1038/onc.2009.44119946328
|
|
10.
|
A UnruhA ResselHG MohamedThe
hypoxia-inducible factor-1 alpha is a negative factor for tumour
therapyOncogene2232133220200310.1038/sj.onc.120638512761491
|
|
11.
|
KJ WilliamsBA TelferD XenakiEnhanced
response to radiotherapy in tumours deficient in the function of
hypoxia-inducible factor-1Radiother
Oncol758998200510.1016/j.radonc.2005.01.00915878106
|
|
12.
|
BJ MoellerMW DewhirstHIF-1 and tumour
radiosensitivityBr J Cancer9515200610.1038/sj.bjc.6603201
|
|
13.
|
R RavizzaR MolteniMB GariboldiE MarrasG
PerlettiE MontiEffect of HIF-1 modulation on the response of two-
and three-dimensional cultures of human colon cancer cells to
5-fluorouracilEur J
Cancer45890898200910.1016/j.ejca.2008.12.02119171477
|
|
14.
|
BM HavelundFB SorensenJ LindebjergKL
SpindlerA JakobsenPretreatment HIF-1α and GLUT-1 expressions do not
correlate with outcome after preoperative chemoradiotherapy in
rectal cancerAnticancer Res31155915652011
|
|
15.
|
E KorkeilaPM JaakkolaK SyrjanenJ
SundstromS PyrhonenPreoperative radiotherapy downregulates the
nuclear expression of hypoxia-inducible factor-1alpha in rectal
cancerScand J
Gastroenterol45340348201010.3109/0036552090348363520001759
|
|
16.
|
Y ToiyamaY InoueS SaigusaGene expression
profiles of epidermal growth factor receptor, vascular endothelial
growth factor and hypoxia-inducible factor-1 with special reference
to local responsiveness to neoadjuvant chemoradiotherapy and
disease recurrence after rectal cancer surgeryClin Oncol (R Coll
Radiol)222722802010
|
|
17.
|
S SaigusaK TanakaY ToiyamaClinical
significance of CD133 and hypoxia inducible factor-1α gene
expression in rectal cancer after preoperative
chemoradiotherapyClin Oncol (R Coll Radiol)23323332201120970309
|
|
18.
|
K TanimotoK YoshigaH
EguchiHypoxia-inducible factor-1alpha polymorphisms associated with
enhanced transactivation capacity, implying clinical
significanceCarcinogenesis2417791783200310.1093/carcin/bgg132
|
|
19.
|
MJ KangSA JungJM JungAssociations between
single nucleotide polymorphisms of MMP2, VEGF, and HIF1A genes and
the risk of developing colorectal cancerAnticancer
Res31575584201121378341
|
|
20.
|
T KuwaiY KitadaiS TanakaSingle nucleotide
polymorphism in the hypoxia-inducible factor-1alpha gene in
colorectal carcinomaOncol Rep1210331037200415492789
|
|
21.
|
B FrankM HoffmeisterN KloppT IlligJ
Chang-ClaudeH BrennerSingle nucleotide polymorphisms in Wnt
signaling and cell death pathway genes and susceptibility to
colorectal
cancerCarcinogenesis3113811386201010.1093/carcin/bgq08220403915
|
|
22.
|
A JakobsenJP MortensenC BisgaardJ
LindebjergJW HansenSR RafaelsenPreoperative chemoradiation of
locally advanced T3 rectal cancer combined with an endorectal
boostInt J Radiat Oncol Biol
Phys64461465200610.1016/j.ijrobp.2005.07.96916226396
|
|
23.
|
A JakobsenJP MortensenC BisgaardJ
LindebjergSR RafaelsenVO BendtsenA COX-2 inhibitor combined with
chemoradiation of locally advanced rectal cancer: a phase II
trialInt J Colorectal
Dis23251255200810.1007/s00384-007-0407-718064474
|
|
24.
|
AKM JakobsenAL AppeltJ LindebjergJ
PloeenSR RafaelsenT VuongThe dose-effect relationship in
preoperative chemoradiation of locally advanced rectal cancer:
Preliminary results of a phase III trialJ Clin Oncol (Meeting
Abstracts)2935122011
|
|
25.
|
AM MandardF DalibardJC MandardPathologic
assessment of tumour regression after preoperative
chemoradiotherapy of esophageal carcinoma. Clinicopathologic
correlationsCancer7326802686199410.1002/1097-0142(19940601)73:11%3C2680::AID-CNCR2820731105%3E3.0.CO;2-C
|
|
26.
|
K FransénM FenechM FredriksonC DabrosinP
SöderkvistAssociation between ulcerative growth and hypoxia
inducible factor-1alpha polymorphisms in colorectal cancer
patientsMol Carcinog45833840200616865676
|
|
27.
|
XS FuE ChoiGJ BubleySP BalkIdentification
of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a
mutation in prostate cancer that prevents normoxia-induced
degradationProstate63215221200510.1002/pros.2019015538748
|
|
28.
|
G KnechtelJ SzkanderaM StotzSingle
nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and
colorectal cancer riskMol Carcinog49805809201020572162
|
|
29.
|
DM AebersoldP BurriKT BeerJ LaissueV
DjonovRH GreinerGL SemenzaExpression of hypoxia-inducible
factor-1alpha: a novel predictive and prognostic parameter in the
radiotherapy of oropharyngeal cancerCancer
Res6129112916200111306467
|
|
30.
|
P SilvaNJ SlevinP SloanPrognostic
significance of tumour hypoxia inducible factor-1alpha expression
for outcome after radiotherapy in oropharyngeal cancerInt J Radiat
Oncol Biol
Phys7215511559200810.1016/j.ijrobp.2008.07.05119028277
|
|
31.
|
ML SchrijversBF van der LaanGH de
BockOverexpression of intrinsic hypoxia markers HIF1alpha and CA-IX
predict for local recurrence in stage T1-T2 glottic laryngeal
carcinoma treated with radiotherapyInt J Radiat Oncol Biol
Phys72161169200810.1016/j.ijrobp.2008.05.025
|
|
32.
|
B BachtiaryM SchindlR PotterOverexpression
of hypoxia-inducible factor 1alpha indicates diminished response to
radiotherapy and unfavorable prognosis in patients receiving
radical radiotherapy for cervical cancerClin Cancer
Res9223422402003
|
|
33.
|
P BurriV DjonovDM AebersoldSignificant
correlation of hypoxia-inducible factor-1alpha with treatment
outcome in cervical cancer treated with radical radiotherapyInt J
Radiat Oncol Biol
Phys56494501200310.1016/S0360-3016(02)04579-012738326
|
|
34.
|
RM ChristleyPower and error: Increased
risk of false positive results in underpowered studiesOpen
Epidemiol J31619201010.2174/1874297101003010016
|
